All in News

Aloe Introduces Itself

It soothes scorched and sunburned skin and takes the rage out of a rash, but now aloe vera is taking an even juicier role on the summer stage as an increasingly popular drink. Awash with speculation on a plethora of rumored health benefits, aloe nevertheless may fall short of a miracle cure, but producers say it does help with digestion and vitamin absorption. While there may not be enough clinical data to say for sure on many of the wilder claims, the fact remains that it’s a fast-growing ingredient, and beverages made with it are finding increasing acceptance.

Marketers Shrug Off Proposed Oversight

Citing the increasing popularity of energy drinks and other dietary supplements, U.S. Sen. Dick Durbin (D-Ill.) has introduced legislation that could require marketers to register their products with the Food and Drug Administration.

Despite the increased layer of regulation the Dietary Supplement Labeling Act would entail, energy drink manufacturers contacted by BevNET remained sanguine about the measure.

Pediatricians — Keep Kids Away From Sports Drinks, Energy Drinks

The findings from a recent study released by the American Academy of Pediatrics indicate that energy drinks and sports drinks can be dangerous for children. While sports drinks are often marketed to kids, and energy drinks are occasionally consumed by athletes of all ages, the AAP says children often can’t tell the difference between the two types of products. Mixing them up means children may drink unnecessary amounts of caffeine while attempting to re-hydrate. These categories are often marketed for kids, but caffeine isn’t good for children, according to the AAP.

POM Wonderful FTC Hearing Underway

In a case that many are looking to for direction with regard to future food and beverage health claims, a Federal Trade Commission action against POM Wonderful began yesterday in Los Angeles, according to an article on Bloomberg.com. The case is a testing ground for treating food and beverage health claims more like those of the pharmaceutical industry. But it is also an opportunity for companies to argue that their claims are supported by the first amendment and cannot be censored, even if they are found to be untrue.